• Skip to main content
  • Skip to primary sidebar
  • Skip to footer

UBRF: UberBrain Research Frontier

Meeting the Challenge of Healthcare Transformation

  • About
    • Research Frontiers
    • Vision & Mission
    • Our Manifesto
  • Team
    • Vivek Misra
    • Poornima Rajan-Misra
  • Core Services
    • Research Consulting
    • Innovation Management
  • Work
    • Publications
    • White Papers
  • Journal
  • Contact

September 22, 2011 By Vivek Misra Leave a Comment

Genetics behind Schizophrenia Revealed

At least half of schizophrenia patients who have no family history of the disorder harbor de novomutations, according to research published online on Sunday (August 7) in Nature Genetics, suggesting genetics may play a role even when the disease is not inherited.  Specifically, researchers sequenced the exomes, or protein-coding DNA, of 53 patients with non-inherited cases of schizophrenia—meaning they had no immediate family members nor aunts, uncles, nieces, nephews or grandparents who had the disease—as well as 22 unaffected individuals and the parents of these subjects. In 27 of the schizophrenia patients, they identified 40 new mutations in 40 different genes, including one in DGCR2, a gene located in a region of chromosome 22 known to be associated with schizophrenia.

Lead researcher Maria Karayiorgou of Columbia University in New York told the BBC that “The fact that the mutations are all from different genes is particularly fascinating, It suggests that many more mutations than we suspected may contribute to schizophrenia”

The reason so many different genes carried new mutations likely stems from the fact that the disease is so complex and involves a variety of genetic pathways, providing a large target for mutations. This, combined with the high rate of mutations that affected protein structure and function, could explain why the disease is so common, affecting about one in every 100 people, the authors said.

ResearchBlogging.org
Xu, B., Roos, J., Dexheimer, P., Boone, B., Plummer, B., Levy, S., Gogos, J., & Karayiorgou, M. (2011). Exome sequencing supports a de novo mutational paradigm for schizophrenia Nature Genetics, 43 (9), 864-868 DOI: 10.1038/ng.902

Share this:

  • Twitter
  • Facebook
  • LinkedIn
  • Pocket
  • WhatsApp
  • Reddit
  • More
  • Tumblr
  • Pinterest
  • Email
  • Print

Filed Under: Clinical Neuroscience

Vivek Misra

Clinical Neuroscientist | Founder Uberbrain Research Frontier.
Join Me: Twitter / LinkedIN

Reader Interactions

Leave a Reply Cancel reply

Primary Sidebar

Email Newsletter

Get The UberBrain in Your Inbox!

Trends

  • Clinical Neuroscience
  • Healthcare
  • Medical Technology
  • Mental Health
  • Neuromodulation

Recent Posts

  • What is Transcutaneous Vagus Nerve Stimulation (tVNS)?
  • What is Transcranial Direct Current Stimulation?
  • What is Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy?

Footer

Contact Us

Email – info [at] ubrf.org

9444 222 050

About Us

UBRF develops Strategies and Innovation Systems focused upon Neuroscience and Mental Health Research.

Learn More.

Follow Us

  • Facebook
  • LinkedIn
  • RSS
  • Twitter

Copyright © 2023 Uberbrain Research Frontier

  • Terms Of Use
  • Medical Disclaimer
  • Privacy Policy